capital raising question, page-3

It could be the Ensis and Eureka results on formulations - these are overdue.

Then we'll be into the next stage of bioassays and analysis as set out in the half yearly.

"Stage 1 of the project will cover bioassay analysis, analytical methods and biochemical properties on the compound and the end use products being developed by BioProspect and other contracted parties. This is expected to take approximately 6 months with key milestones related to efficacy of the compound on termites tested under Australian and international standards. "

News on Astrum is also due soon.

"Since June 2006 Astrum has had two new chemical entities (NCE’s) produced. The optional delivery of an additional four NCE’s may take place in March quarter 2007."